Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9475	Companies
185452	Keywords
117793	Articles
99303	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 03/19/2024 at 09:47, 1 year 8 months ago

Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty
Heidelberg Pharma receives USD 25 million upfront cash payment from HealthCare Royalty for royalty purchase agreement. Funds to advance ADC pipeline development and extend cash runway

Heidelberg Pharma HealthCare Royalty ADC Pipeline Royalty Purchase Agreement Cash Payment
BRIEF

published on 03/18/2024 at 07:30, 1 year 8 months ago

Heidelberg Pharma Advances to Cohort 6 in Multiple Myeloma Study with HDP-101

Heidelberg Pharma HDP-101 Multiple Myeloma Phase I/IIa Study Cohort 6
BRIEF

published on 03/18/2024 at 07:30, 1 year 8 months ago

Heidelberg Pharma passe à la cohorte 6 dans l'étude sur le myélome multiple avec HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple Étude De Phase I/IIa Cohorte 6
PRESS RELEASE

published on 03/18/2024 at 07:25, 1 year 8 months ago

Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study
Heidelberg Pharma progresses into Cohort 6 with ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study, showing first objective responses and partial remissions. Amended protocol includes optimized dosing regimens

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study ATAC Candidate Protocol Amendment
PRESS RELEASE

published on 03/07/2024 at 12:27, 1 year 8 months ago

Original-Research: Heidelberg Pharma AG (von EQUITS GmbH): Kaufen
EQUI.TS GmbH bekräftigt Anlageurteil KAUFEN für Heidelberg Pharma AG nach Royalty-Verkauf an HCRx, der die F&E Aktivitäten beschleunigt und das ZircaixTM Potential um 50% steigert

Heidelberg Pharma AG EQUI.TS GmbH Royalty-Verkauf ZircaixTM Potential F&E Aktivitäten
BRIEF

published on 03/06/2024 at 07:51, 1 year 8 months ago

Heidelberg Pharma to Showcase HDP-101 Efficacy and ADC Technology at AACR 2024

Cancer Research Heidelberg Pharma HDP-101 ADC Technology AACR Meeting 2024
BRIEF

published on 03/06/2024 at 07:51, 1 year 8 months ago

Heidelberg Pharma présentera l'efficacité du HDP-101 et la technologie ADC à l'AACR 2024

Recherche Contre Le Cancer Heidelberg Pharma HDP-101 Technologie CAN Réunion AACR 2024
PRESS RELEASE

published on 03/06/2024 at 07:46, 1 year 8 months ago

Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024
Heidelberg Pharma to present first efficacy data on HDP-101 and data from proprietary ADC technology platform at AACR Meeting 2024. Details of ATAC and ADC-based cancer therapies

Clinical Trials Heidelberg Pharma ADC Technology AACR Meeting 2024 ATAC Therapies
BRIEF

published on 03/04/2024 at 11:24, 1 year 9 months ago

Heidelberg Pharma Secures Up to $115 Million in Royalty Financing from HealthCare Royalty

Biopharmaceuticals Heidelberg Pharma HealthCare Royalty Royalty Financing ZircaixTM
BRIEF

published on 03/04/2024 at 11:24, 1 year 9 months ago

Heidelberg Pharma obtient jusqu'à 115 millions de dollars de financement en redevances auprès de HealthCare Royalty

Heidelberg Pharma Redevance En Matière De Soins De Santé Financement Des Redevances ZircaixTM Produits Biopharmaceutiques

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 38 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 43 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 12 hours 13 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 8 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 13 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:00, 13 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 13 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 8 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 13 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 13 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million

Les Echos

Published on 12/05/2025 at 08:45, 4 hours 28 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 28 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 30 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 58 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 19 hours 13 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE